Aristotle University Of Thessaloniki (AUTH)
Πεπτίδια ρύθμισης πρόσληψης τροφής σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 πριν και μετά από ινσουλινοθεραπεία
Abstract
dc:descriptionSeveral peptides involved in the regulation of food intake and energy expenditure, including leptin, adiponectin, ghrelin and neuropeptide Y (NPY), may be implicated in the obesity seen in the majority of patients with type 2 diabetes mellitus (T2DM). Leptin is a potent anorexic hormone produced mainly by adipose tissue that acts on the hypothalamus to regulate food intake and energy balance. Furthermore, leptin affects vascular cells function, exerting inflammatory and atherogenic properties. Adiponectin, a protein exclusively synthesized in white adipose tissue, exerts pleiotropic actions such as anti-inflammatory, antiatherogenic and insulin-sensitizing. With regard to weight regulation, adiponectin may lead to weight reduction via increased energy expenditure. Ghrelin is a growth hormone secretagogue, predominantly synthesized in the stomach that enhances appetite and food intake. NPY is the most potent orexigenic neurotransmitter in the brain, also known to exert peripheral actions, such as vasoconstriction, angiogenesis and lipogenesis. Patients with T2DM have either lower or similar leptin, decreased adiponectin and ghrelin and increased NPY circulating levels compared with nondiabetic controls. Treatment with insulin, oral hypoglycemic, antihypertensive, hypolipidemic, antiobesity and antiplatelet drugs may influence the levels of these peptides. Insulin therapy is associated with weight gain in T2DM. Possible causes of this include anabolic effects of insulin, improvement of dehydration, reduction of basal metabolic rate, suppression of hepatic glucose production, elimination of glycosuria and augmented calorie intake due to both fear of hypoglycemia and a feeling of freedom to eat based on the false impression of adequate glycemic control. The role of the peptides involved in food intake regulation in insulin-associated weight increase has not been fully elucidated yet. In the present study, we evaluated the effects of insulin-induced improved glycemic control on leptin, adiponectin, ghrelin and NPY levels. Consecutive T2DM patients (n=90) were divided into 2 groups: group A: 45 insulin-naive uncontrolled (glycosylated hemoglobin A]c: HbAlc > 7%) patients on oral hypoglycaemic agents (OHAs) who converted to insulin monotherapy; group B: 45 well-controlled (HbAlc < 7%) patients on OHAs. Both groups were monitored at baseline, 3 and 6 months. Males and females were analyzed separately because some hormone levels differ between genders. In both genders, insulin therapy (group A) was associated with significant (p = 0.003 to < 0.001) increases in weight, body mass index and leptin levels and significant decreases in glucose, HbAlc and NPY levels (p < 0.001 for all comparisons). In male insulin-treated patients a significant increase in adiponectin levels (p = 0.008) was also observed. There were significant correlations (p = 0.016 to < 0.001) between leptin levels, waist circumference and body fat in all patient groups, except group B males. In conclusion, changes in leptin, adiponectin and NPY levels may occur after insulin-induced improved glycémie control. These changes may be influenced by gender, weight, body fat and HbAlc. Although leptin levels were increased and NPY levels were decreased, insulin-treated T2DM patients gained weight; a finding partly explained by the development of leptin resistance that characterizes DM. Further research is needed to clarify the multifaceted mechanisms of appetite control and food intake regulation and their disturbances in pathological conditions such as obesity and T2DM.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsiki, Niki
- Κατσίκη, Νίκη
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26051